Skip to main
  1. Stocks
  2. Revvity Inc
  3. Forecast
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 8%
Buy 23%
Hold 69%
Sell 0%
Strong Sell 0%

Bulls say

Revvity is viewed favorably because its Life Sciences segment is reaccelerating, with 9% organic sales growth well above the 5.5% estimate, improving instrument demand, and stronger reagent trends supported by recovering biopharma and academic spending. Diagnostics also looks more durable and profitable, as pro forma gross margin reached 62.4% and Diagnostics operating margin improved nearly 900 bps quarter over quarter, aided by the Euroimmun restructuring and resilient immunodiagnostics and reproductive health demand. The outlook is further strengthened by Signals’ sticky software base, broad AI-related tailwinds, and new launches like Xynthetica, BioDesign, and LabGistics, which could support above-LRP growth and higher-margin revenue streams.

Bears say

Revvity is facing a fundamental growth gap because its two largest businesses, Immunodiagnostics and Life Sciences Solutions, represent about 70% of revenue yet still need clear acceleration to justify the long-range plan. Diagnostics organic growth of 5% slightly missed the 5.5% forecast, ex-China immunodiagnostics ran at +MSD/HSD% versus a 9–11% expectation, and Life Sciences Solutions only recently returned to +LSD% growth after contracting in 2024 and 2025. Reproductive health is also set up less favorably as GEL annualizes in Q4 '26, global birth rates are declining, and competition is intensifying from BD/Waters, Abcam/Danaher, Roche, Diasorin, and AI-native software rivals.

Revvity Inc (RVTY) has been analyzed by 13 analysts, with a consensus rating of Hold. 8% of analysts recommend a Strong Buy, 23% recommend Buy, 69% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Revvity Inc (RVTY) Analyst Forecast & Price Prediction

Get the latest Revvity Inc (RVTY) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Revvity Inc (RVTY)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Hold based on their latest research and market trends.

According to 13 analysts, Revvity Inc (RVTY) has a Hold consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $140.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $140.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Revvity Inc (RVTY) Analyst Forecast & Price Prediction

Get the latest Revvity Inc (RVTY) stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in Revvity Inc (RVTY)

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover RVTY stock data and trends